Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- Monoclonal antibodyPhase 22 trials
Immunocore Ltd · Cancer, HLA-A*02:01-positive, Refractory Cancer
- MR-VACPhase 22 trials
GSK · Diarrhoea
- MRG006APhase 22 trials
Lepu Biopharma Co., Ltd. · Advanced Solid Tumors, Hepatocellular Carcinoma
- MRT-2359Phase 22 trials
Monte Rosa Therapeutics, Inc · Prostate Cancer, NSCLC, SCLC
- MT-125Phase 22 trials
Myosin Therapeutics Inc. · Glioblastoma (GBM), Glioblastoma
- MWN109 4Phase 22 trials
Shanghai Minwei Biotechnology Co., Ltd · Type 2 Diabetes Mellitus (T2DM), Overweight , Obesity
- NBM-BMXPhase 22 trials
Novelwise Pharmaceutical Corporation · Malignant Neoplasm of Brain, Malignant Neoplasm
- NE3107bezisterimPhase 22 trials
BioVie Inc. · Long COVID, Parkinsons Disease (PD)
- NelistotugGSK6097608Phase 22 trials
GSK · Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck
- NelmastobartPhase 22 trials
STCube, Inc. · Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer, Non Small Cell Lung Cancer
- NEO100Perillyl alcoholPhase 22 trials
Neonc Technologies, Inc. · Glioblastoma Multiforme, Residual, Progressive or Recurrent Grade II or III Meningioma
- NKX019Phase 22 trials
Nkarta, Inc. · Lupus Nephritis, Primary Membranous Nephropathy, Systemic Sclerosis
- NLM-001Phase 22 trials
Nelum Corp · Untreated, Advanced Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
- NNC0194-0499Phase 22 trials
Novo Nordisk · Alcohol-related Liver Disease, Non-alcoholic Steatohepatitis
- Normal Saline alongPhase 22 trials
Pharmazz, Inc. · Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, Neonatal Encephalopathy
- NS-863Phase 22 trials
NS Pharma, Inc. · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD), Pulmonary Arterial Hypertension
- NT-0796Phase 22 trials
NodThera Ltd. (a Rezera company) · Obesity and Type 2 Diabetes, Obesity
- NT-101Phase 22 trials
NexThera Co., Ltd. · Wet Age Related Macular Degeneration, Wet AMD
- NWRD09Phase 22 trials
Newish Biotech (Wuxi) Co., Ltd. · High-grade Squamous Intraepithelial Lesion (HSIL), Persistent HPV16 Infection
- ODM-212Phase 22 trials
Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer
- of QLS1410Phase 22 trials
Qilu Pharmaceutical Co., Ltd. · Hypertension (HTN), Uncontrolled Hypertension
- of TQH2722Phase 22 trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Sinusitis, Chronic Rhinosinusitis
- OfirnoflastHT-6184Phase 22 trials
Halia Therapeutics, Inc. · Myelodysplastic Syndromes, Anemia, Myelodysplastic Syndrome
- Olaptesed pegolNOX-A12Phase 22 trials
TME Pharma AG · Metastatic Pancreatic Cancer, Glioblastoma
- ONC206JZP3507Phase 22 trials
Jazz Pharmaceuticals · Meningioma, Advanced Pheochromocytoma and Paraganglioma, PCPG
- ONO-2020Phase 22 trials
Ono Pharmaceutical Co., Ltd. · Agitation Associated With Alzheimer's Disease Dementia, Alzheimer Disease
- OnvansertibPhase 22 trials
Cardiff Oncology · Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation
- OpRegenPhase 22 trials
Roche (Genentech) · Age-Related Macular Degeneration, Geographic Atrophy
- ORKA-001Phase 22 trials
Oruka Therapeutics, Inc. · Plaque Psoriasis
- ORX750Phase 22 trials
Centessa Pharmaceuticals (UK) Limited · Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
- OsrhCTRecombinant Human Chymotrypsin 4000UPhase 22 trials
Healthgen Biotechnology Corp. · Gastric Mucosal Lesion
- PA9159 Metered-DosePhase 22 trials
Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma
- paridiprubartPhase 22 trials
PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)
- parsaclisibINCB050465Phase 22 trials
Incyte · Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma, B-Cell Malignancies
- PD-L1 monoclonal antibodyPhase 22 trials
Suzhou BlueHorse Therapeutics Co., Ltd. · Non-Small Cell Lung Cancer, Advanced Malignant Solid Tumor
- Pentavalent Meningococcal ABCYW vaccineMenPentaPhase 22 trials
Sanofi · Healthy Volunteers, Meningococcal Immunization, Meningococcal Immunisation
- per day for 28 daysPhase 22 trials
Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma
- PER-001 Intravitreal ImplantPhase 22 trials
Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma
- PER-001 Intravitreal Implant - ShamPhase 22 trials
Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma
- Personalized Neoantigen Peptide VaccinePhase 22 trials
Seqker Biosciences, Inc. · Solid Tumors, Advanced Cancer, Recurrent Cancer
- PEX010-Assisted TherapyPEX010Phase 22 trials
Filament Health Corp. · Stimulant Use Disorder, Opioid Use Disorder
- PF-07104091ovarian, SCLCPhase 22 trials
Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer
- PGN-EDODM1Phase 22 trials
PepGen Inc · Myotonic Dystrophy 1
- PM54Phase 22 trials
PharmaMar · Advanced Solid Tumor, Advanced Malignancies
- PRA-216Phase 22 trials
Prana Therapies Inc · Chronic Obstructive Pulmonary Disease (COPD), Mild to Moderate Asthma
- Prizloncabtagene AutoleucelC-CAR039Phase 22 trials
AbelZeta Inc. · Large B Cell Lymphoma, LBCL, Diffuse Large B Cell Lymphoma (DLBCL)
- ProgerininPhase 22 trials
PRG Science & Technology Co., Ltd. · Werner Syndrome, Hutchinson-Gilford Progeria Syndrome
- QHL-1618ALK-N001Phase 22 trials
Zhejiang Anglikang Pharmaceutical Co., Ltd. · Advanced Gastrointestinal Tumors, Advanced Solid Tumors
- QLC1401Phase 22 trials
Qilu Pharmaceutical Co., Ltd. · Advanced Breast Cancer, Advanced ER+/HER2- Breast Cancer
- QLH12016Phase 22 trials
Qilu Pharmaceutical Co., Ltd. · Prostatic Neoplasms, Advanced Prostate Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.